Upgrade to SI Premium - Free Trial

Rosenblatt Remains Cautious on Himax (HIMX) Post Q3

November 9, 2017 11:57 AM
Rosenblatt analyst Jun Zhang reiterated a Sell rating and $6 price target on Himax Technologies (NASDAQ: HIMX) following results. Zhang ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles